+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Functional evaluation of inhibition of autonomic transmitter release by autoantibody from Lambert-Eaton myasthenic syndrome

Functional evaluation of inhibition of autonomic transmitter release by autoantibody from Lambert-Eaton myasthenic syndrome

Annals of Neurology 43(5): 677-680

The effects of the anti-voltage-gated Ca2+ channel (VGCC) antibody obtained from patients with Lambert-Eaton myasthenic syndrome (LEMS) on autonomic neurotransmission were studied in in-vitro experiments. The releases of acetylcholine (ACh) and norepinephrine from the autonomic nerves were evaluated by changes in the contractile responses of guinea pig taenia caeci and left atria to electric field stimulation, respectively. Incubations for 6 hours with LEMS serum and IgG, both of which contain anti-VGCC antibody, markedly suppressed the parasympathetic response but did not affect the sympathetic response. Pharmacological experiments with specific blockers to the VGCC subtypes showed that the Q-type VGCC is closely linked to the genesis of the parasympathetic response. We suggest that the anti-VGCC antibody from the LEMS patients specifically reduces the ACh release from the parasympathetic nerve by binding to the Q-type VGCC.

(PDF emailed within 0-6 h: $19.90)

Accession: 008709596

Download citation: RISBibTeXText

PMID: 9585366

DOI: 10.1002/ana.410430520

Related references

Effect of passively transferred lambert eaton myasthenic syndrome antibodies on the calcium sensitivity of transmitter release in the mouse. Journal of Physiology (Cambridge) 357: 28P, 1984

Mechanisms of functional impairment of the autonomic nervous system in the lambert eaton myasthenic syndrome. Soviet Neurology & Psychiatry 23(1): 73-82, 1990

Mechanisms of functional disorders of the autonomic nervous system in Lambert-Eaton myasthenic syndrome. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 87(11): 1625-1629, 1987

Autoantibody specificities in Lambert-Eaton myasthenic syndrome. Annals of the New York Academy of Sciences 681: 382-393, 1993

Autoantibody activity in Lambert-Eaton myasthenic syndrome. Lancet 1(8591): 920-920, 1988

Quantification of autonomic dysfunction Lambert-Eaton myasthenic syndrome by composite autonomic scoring scale. Neurology 44(4 SUPPL 2): A220, 1994

Autonomic dysfunction in Lambert-Eaton myasthenic syndrome. Journal of the Neurological Sciences 85(1): 77-86, 1988

The proteins synaptotagmin and syntaxin are not general targets of Lambert-Eaton myasthenic syndrome autoantibody. Journal of Neurochemistry 64(3): 1245-1251, 1995

Abnormalities of autonomic function in the Lambert Eaton myasthenic syndrome. Journal of Neurology, Neurosurgery, and Psychiatry 51(3): 436-439, 1988

Specificity of the lambert eaton myasthenic syndrome lems autoantibody for nerve terminal calcium channels. Society for Neuroscience Abstracts 17(1-2): 1610, 1991

Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome. Brain and Nerve 65(4): 441-448, 2013

Ocular autonomic nerve function in lambert eaton myasthenic syndrome. Eye (London) 4(3): 473-481, 1990

Autonomic dysfunction in the Lambert-Eaton myasthenic syndrome: serologic and clinical correlates. Neurology 50(1): 88-93, 1998

Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse. Annals of Neurology 42(2): 147-156, 1997